• The Ebola outbreak in DRC was identified to have started in February, prior to its May declaration.
• Currently, over 4,200 cases and nearly 1,900 deaths have been recorded.
• The outbreak involves the Bundibugyo strain, which lacks approved vaccines or treatments.
• Insecurity in the region has severely hindered health response efforts.
• WHO officials state they are "chasing the virus," which is spreading faster than containment measures.

The World Health Organization (WHO) has confirmed that the current Ebola outbreak in the Democratic Republic of Congo (DRC) began in February, months before its official declaration on May 15. This delayed recognition has led to a significant number of missed cases, as early instances were misattributed to other diseases like malaria and typhoid. As a result, health responders are struggling to keep pace with the viral spread, described by WHO's regional director for Africa, Mohamed Janabi, as "chasing the virus" which is now "ahead of us," according to South China Morning Post and Al Jazeera.

As of now, the DRC has reported 4,294 confirmed cases and approximately 1,960 deaths, making it the second-worst Ebola outbreak recorded. The outbreak is predominantly affecting eastern regions of the country, where healthcare access is severely compromised due to ongoing insecurity and health worker strikes related to unpaid wages. Traditional burial practices among local communities have also complicated containment efforts, as mourning customs involve touching the deceased, thereby increasing the risk of transmission. These conditions underline the challenges faced in combating this outbreak, as highlighted by BBC and South China Morning Post.

The Bundibugyo virus responsible for this outbreak has no approved vaccines or therapeutic options, making treatment particularly challenging. The WHO has noted that previous outbreaks in the region have also experienced delays in declaration and response. Current vaccinations under trial aim to address the specific strain of the virus, with WHO recommending the commencement of human trials for the Ervebo vaccine, which may provide some level of protection against the outbreak. The urgency of these measures stems from escalating infection rates, with new cases reportedly doubling in certain hotspots, according to Al Jazeera and BBC.